In addition, EMT biomarkers CDH1 and VIM were highly expressed in cancer cells, consistent with previous reports showing that TAM promoted EMT progress of cancers (lung cancer, colorectal cancer, breast cancer and ovarian cancer) by SPP1[64]. The gene discussed is CDH1; the disease is breast carcinoma.